The Year in Cardiology—Practice Changing Trials from European Society of Cardiology Congress 2023

The European Society of Cardiology annual congress is the premier global platform for dissemination and unraveling major scientific advances in the field of cardiology. Each year a myriad number of scientific ideas are exchanged at this meeting and many major path-breaking clinical trials are presented that have the potential to alter our practice. Last year was not different and more than 30 clinical trials spanning various facets of cardiology were unveiled and discussed—heart failure, lipid lowering, coronary intervention, intracoronary imaging, cardiomyopathies, anticoagulation, atrial fibrillation, antiplatelet therapy, etc. We present a brief summary of 10 major trials which in the view of authors have the potential for impacting daily cardiology practice. In each study, we also attempt to provide a contemporary perspective and the way forward. We aim to provide a glimpse on the major advances in the field of cardiology in the past year.

Keywords semaglutide - stent thrombosis - acute heart failure - frailty - complete revascularization - subclinical AF - bifurcation lesion - postprocedural anticoagulation - cardiac myosin inhibitors - statins

A.P., U.T., and A.S. conceptualized the study and prepared the manuscript. A.P. and U.T. designed the study, and contributed to literature search and manuscript editing. A.P. and A.S. contributed to definition of intellectual content and manuscript review. A.P. is the guarantor.

© 2024. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

留言 (0)

沒有登入
gif